T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.31B |
| 2 |
Home Depot
HD
|
+$1.07B |
| 3 |
Alibaba
BABA
|
+$1.06B |
| 4 |
Yum! Brands
YUM
|
+$887M |
| 5 |
Honeywell
HON
|
+$860M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
N
Netsuite Inc
N
|
+$1.59B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.33B |
| 3 |
Danaher
DHR
|
+$1.13B |
| 4 |
HBI
Hanesbrands
HBI
|
+$1.06B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$845M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.86% |
| 2 | Healthcare | 16.8% |
| 3 | Consumer Discretionary | 15.02% |
| 4 | Technology | 13.29% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Alnylam Pharmaceuticals
ALNY
$30.4B
| $156M | 0.03% |
4,163,714
+138,306
| +3% | +$5.79M |
|
|
MJN
477
DELISTED
Mead Johnson Nutrition Company
MJN
| $155M | 0.03% |
2,189,663
+1,167,408
| +114% | +$87M |
|
478
Strategic Education
STRA
$1.86B
| $154M | 0.03% |
1,911,637
-92,500
| -5% | -$6.04M |
|
479
Entergy
ETR
$49.9B
| $154M | 0.03% |
4,193,838
-4,284,874
| -51% | -$154M |
|
|
ONCE
480
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $152M | 0.03% |
3,041,716
+135,220
| +5% | +$7.24M |
|
481
RH
RH
$3.4B
| $152M | 0.03% |
4,938,206
-637,930
| -11% | -$20.6M |
|
|
ALEX
482
DELISTED
Alexander & Baldwin
ALEX
| $151M | 0.03% |
3,363,823
-6,700
| -0.2% | -$279K |
|
483
CALL
Bristol-Myers Squibb
BMY
$132B
| $150M | 0.03% |
+2,560,000
| New | +$140M |
|
484
SLM Corp
SLM
$5.22B
| $148M | 0.03% |
13,466,025
+3,906,269
| +41% | +$35.1M |
|
|
PGRE
485
DELISTED
Paramount Group
PGRE
| $148M | 0.03% |
9,273,679
+173,764
| +2% | +$2.74M |
|
486
Invesco
IVZ
$14.3B
| $148M | 0.03% |
4,882,802
+736,913
| +18% | +$22.7M |
|
487
Omnicom Group
OMC
$24.2B
| $148M | 0.03% |
1,737,836
+52,616
| +3% | +$4.41M |
|
488
Ally Financial
ALLY
$13.6B
| $145M | 0.03% |
7,644,427
+2,493,743
| +48% | +$48M |
|
489
Belden
BDC
$5.36B
| $145M | 0.03% |
1,943,519
-20,755
| -1% | -$1.48M |
|
490
Edgewell Personal Care
EPC
$1.31B
| $145M | 0.03% |
1,984,700
+7,599
| +0.4% | +$588K |
|
|
DNKN
491
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $145M | 0.03% |
2,759,866
+1,028,387
| +59% | +$52.9M |
|
492
Micron Technology
MU
$1.07T
| $144M | 0.03% |
6,567,208
-4,011,638
| -38% | -$75.4M |
|
493
McCormick & Company Non-Voting
MKC
$14.6B
| $144M | 0.03% |
3,076,792
-637,258
| -17% | -$29.7M |
|
|
TIF
494
DELISTED
Tiffany & Co.
TIF
| $143M | 0.03% |
1,850,587
-228,070
| -11% | -$17.6M |
|
495
Choice Hotels
CHH
$4.71B
| $142M | 0.03% |
2,541,254
-3,284,733
| -56% | -$165M |
|
496
Banco Santander Chile
BSAC
$16.1B
| $142M | 0.03% |
6,500,319
-397,062
| -6% | -$8.69M |
|
497
Cognizant
CTSH
$26.7B
| $142M | 0.03% |
2,536,095
+394,980
| +18% | +$21.1M |
|
498
Vipshop
VIPS
$6.8B
| $142M | 0.03% |
12,870,749
-1,894,690
| -13% | -$24.5M |
|
499
General Dynamics
GD
$106B
| $141M | 0.03% |
816,652
+223,025
| +38% | +$36.5M |
|
500
Eversource Energy
ES
$27.2B
| $141M | 0.03% |
2,544,087
+1,940,978
| +322% | +$104M |
|
Similar funds
T. Rowe Price Associates's Q4 2016 Portfolio in Review
As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
- T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
- T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
- T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
- T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
- T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.
Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.